source
- STAT+: Longevity, wellness physicians named to panel advising FDA on peptidesThe panel will soon consider whether to relax restrictions on certain peptides.STAT · 1mo ago↗ source
- De-Risking a Rare Disease Launch Starts with PrecisionWhy traditional models fall short in rare disease commercialization—and what works instead.Fierce Biotech · 1mo ago↗ source
- Opinion: Why the space in ‘health care’ mattersWhen STAT polled our readers on ‘health care’ vs. ‘healthcare,’ about 60% of our readers voted for one word.STAT · 1mo ago↗ source